Clinical characteristics | Values | |
---|---|---|
N in patients (n=53) | ||
Age (years), mean (SD) | 70.7 (11.3) | |
Age (years), range | 36– 93 | |
Sex, n (%) | Female | 31 (58.5) |
Patients with bilateral macular disease, n (%) | 36 (67.9) | |
Eye, n (%) | OD | 42 (47.2) |
Total test duration in clinic for both eyes (minutes), mean (SD)** | 17.7 (4.4) | |
N in eyes (n=89) | ||
DVA conventional assessment (LogMAR), mean (SD) | 0.23(0.21) | |
DVA conventional assessment (Snellen) | 20/34 | |
NVA conventional assessment (LogMAR), mean (SD) | 0.37(0.26) | |
NVA conventional assessment (Snellen) | 20/47 | |
Macular Diseases, n (%) | Late-stage AMD | 47 (52.8) |
Early-stage AMD | 11 (12.4) | |
Central Serous Chorioretinopathy with CNV | 14 (15.7) | |
Pseudoxanthoma Elasticum with CNV | 8 (9.0) | |
Other Macular Diseases* | 9 (10.1) |